Improving transportation access for patients with diabetic retinopathy
Using implementation science to adapt a targeted transportation intervention for patients with diabetic retinopathy (PRONTO-EYE)
This study is working to make it easier for people with diabetic retinopathy to get to their eye doctor appointments by improving a ride-share program, so they can keep their vision healthy and avoid preventable blindness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11010017 on NIH RePORTER |
What this research studies
This research focuses on addressing transportation challenges faced by patients with diabetic retinopathy, a condition that can lead to vision loss if not treated promptly. The project aims to adapt an existing ride-share program to help patients attend their ophthalmology appointments more consistently. By using implementation science and human-centered design, the team will co-design and pilot test this transportation intervention, known as PRONTO-EYE, specifically for patients with Medicaid insurance. The goal is to enhance appointment adherence and ultimately reduce preventable blindness in underserved communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with diabetic retinopathy who have Medicaid insurance and face transportation barriers to accessing ophthalmology care.
Not a fit: Patients who do not have diabetic retinopathy or those who do not face transportation challenges may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to eye care for patients with diabetic retinopathy, leading to better health outcomes and reduced vision loss.
How similar studies have performed: Previous research has shown success in using transportation interventions to improve healthcare access, making this approach promising for addressing similar challenges.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Scanzera, Angelica — University of Illinois at Chicago
- Study coordinator: Scanzera, Angelica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.